pBabe-puro-TGFβRII-HA
(Plasmid
#37040)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 37040 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBabe-puro
-
Backbone manufacturerWeinberg Lab
- Backbone size w/o insert (bp) 5169
- Total vector size (bp) 7000
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTGFβRII
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1800
- Promoter 5'LTR
-
Tag
/ Fusion Protein
- HA (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SnaBI (destroyed during cloning)
- 3′ cloning site SnaBI (destroyed during cloning)
- 5′ sequencing primer pBABE5'
- 3′ sequencing primer pBABE3' (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDr. Bert Vogelstein, Johns Hopkins University
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Insert was blunt-ended and ligated into SnaBI-digested pBabe-puro.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBabe-puro-TGFβRII-HA was a gift from Sam Thiagalingam (Addgene plasmid # 37040 ; http://n2t.net/addgene:37040 ; RRID:Addgene_37040) -
For your References section:
Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, Abdolmaleky HM, Zhou JR, Thiagalingam S. Cancer Res. 2011 Feb 1;71(3):998-1008. Epub 2011 Jan 18. 10.1158/0008-5472.CAN-09-3269 PubMed 21245094